Lenvatinib increases progression free survival when used with everolimus in metastatic renal cell carcinoma

Medically under-represented populations: Refining the calculation of accrual targets

Enzalutamide preferable to bicalutamide plus LHRH analogue in prostate cancer

Screening to identify unsuitable candidates for ipilimumab in advanced melanoma

Nivolumab alone superior to ipilimumab alone in advanced melanoma

New dexamethasone combination yields two-fold improvement in median PFS in multiple myeloma

Survival benefits following eribulin in advanced liposarcoma and leiomyosarcoma

ASCO 2015: Latest developments in multiple myeloma

Adjuvant denosumab may preserve bone health in postmenopausal breast cancer patients: results of the ABCSG-18 trial

Randomised trial of pembrolizumab versus standard treatment in patients with recurrent or metastatic head and neck cancer

ASCO 2015: Latest in chronic lymphocytic leukaemia

Cobimetinib plus vemurafenib for advanced BRAF-mutated melanoma